Education Program for people with Chronic Obstructive Pulmonary Disease
Not Applicable
Completed
- Conditions
- chronic obstructive pulmonary diseasesymptoms of anxietysymptoms of depressionRespiratory - Chronic obstructive pulmonary diseaseMental Health - AnxietyMental Health - Depression
- Registration Number
- ACTRN12618001905257
- Lead Sponsor
- The University of Newcastle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Inclusion Criteria
•Male or female outpatients aged 18 years and above with a confirmed diagnosis of COPD (FEV1/FVC <0.70).
•All levels of COPD severity are eligible including mild to moderate and severe to very severe stage.
•Patients are willing to participate in the study and have capacity to provide informed consent.
•Agree to follow the study procedures
•Speak Mandarin
•Able to read and write Chinese
Exclusion Criteria
Exclusion criteria
•People with cognitive impairment such as dementia
•People participated in any other clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method symptoms of depression<br>Hospital Anxiety and Depression Scale will be used to assess the symptoms of depression.[Symptoms of depression will be measured at baseline, immediately after the intervention (Post-test 1), and four weeks after the intervention (Post-test 2).<br>The primary timepoint will be 6 weeks (end of the intervention period)];symptoms of anxiety<br>Hospital Anxiety and Depression Scale will be used to assess the symptoms of anxiety.[Symptoms of anxiety will be measured at baseline, immediately after the intervention (Post-test 1), and four weeks after the intervention (Post-test 2).<br>The primary timepoint will be 6 weeks (end of the intervention period)]
- Secondary Outcome Measures
Name Time Method Self-efficacy <br>COPD Self-efficacy Scale will be used to assess self-efficacy.[Self-efficacy will be measured at baseline, immediately after the intervention (Post-test 1), and four weeks after the intervention (Post-test 2).];Quality of Life<br>St George's respiratory questionnera will be used to assess the quality of life of the participants.[Health-related quality of life will be measured at baseline, immediately after the intervention (Post-test 1), and four weeks after the intervention (Post-test 2).]